Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights
2020 · Scientific Reports · 62 citations
https://doi.org/10.1038/s41598-020-71157-w
H
Hesham Saeed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
1.3K
Citations
20
h-index
33
i10-index
Hesham Saeed is an academic researcher from Ain Shams University. The author has contributed to research in topics: Enzyme Catalysis and Immobilization & Microbial Metabolic Engineering and Bioproduction & Acute Lymphoblastic Leukemia research. The author has an h-index of 20, co-authored 71 publications.
ORCID: 0000-0001-6600-1338Papers by this author
worksOptimization and characterization studies of poultry waste valorization for peptone production using a newly Egyptian Bacillus subtilis strain
2025 · AMB Express · 7 citations
https://doi.org/10.1186/s13568-024-01794-1
Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy
2025 · Chemical Engineering Journal · 4 citations
https://doi.org/10.1016/j.cej.2025.163015
Additional file 1 of SNP (A > G - rs13057211) but not GT(n) polymorphism in HMOX-1 promotor gene is associated with COVID-19 mortality
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24892867
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat